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DRUG-RESISTANT TB IS 
HARDER TO DIAGNOSE 
• Requires laboratory tests not easily 
accessible to patients
• Often requires weeks to months to 
diagnose accurately
• Fewer than 1 in 5 MDR TB cases are 
diagnosed and started on treatment 
DRUG-RESISTANT TB 
IS HARDER TO CURE
• Requires 2 years of treatment vs. 6 months
(which costs 10-30 times more)
• Requires 15,000 pills vs. <750
• Certain drugs are more toxic and cause long-
term side e˜ects
• Fewer than half of patients treated are cured; 
only 1 in 10 of all MDR TB cases are cured 
The Urgent Threat  
of TB Drug Resistance
DRUGRESISTANT TB THREATENS TO ERASE 
DECADES OF PROGRESS
spread globally. Drug-resistant TB strains 
are more difficult to cure and costly to 
our economy and health system. Because 
TB is airborne and contagious, the 
continued spread of drug-resistant TB 
could cause a resurgence of TB in parts of 
the world where TB is currently less 
common, including the United States.  
That is why CDC works to fight TB at 
home and abroad to help create a safer 
America and a safer world.
To prevent further spread of drug-resistant 
TB, we must find and cure all cases of MDR 
TB. But equally important is ensuring  
drug-susceptible TB cases are properly 
diagnosed and treated, so those strains do 
MDR TB IS HARDER TO FIND, TREAT AND CURE
DRUG-RESISTANT TB STRAINS ARE 
BECOMING MORE WIDESPREAD  
MDR TB (Multidrug-resistant TB): 
Resistant to the best two anti-TB drugs –  
reported in every country in the world
XDR TB (Extensively drug-resistant TB): 
Resistant to the best first-line drugs and at least 
two second-line drugs – reported in more than 
100 countries
drug-susceptible TB cases are properly 
diagnosed and treated, so those strains do 
not develop drug resistance and start the 
cycle anew. To stop drug-resistant TB, we 
must get back to the basics of effective 
TB prevention and treatment.
THE  TIME IS NOW  
In 2016, 490,000 people become sick 
with MDR TB, leading to 240,000 deaths. 
Recent estimates suggest that by 2050, if 
we do not act to contain these strains, 
more than 2.6 million people will die from 
MDR TB every year, costing the global 
economy a collective $17 trillion in lost 
productivity. 
Nearly 2 billion people are infected 
with TB, and 10.4 million people 
become sick with active TB disease 
each year. TB is the leading cause of 
death from an infectious disease 
globally and claims 1.7 million lives 
each year, even though we have had 
a cure for more than 70 years. In some 
cases of TB, the bacteria that causes 
infection has been able to develop 
resistance to the anti-TB drugs used to 
cure it. Most often, this stems from 
incomplete treatment of non-resistant 
TB. In recent decades, these strains have 
become resistant to more and more of 
our best drugs and continue to 
CDC IS A LEADING PARTNER IN THE FIGHT AGAINST MDR TB 
CDC is committed to the global goal to End TB by 2035. To address drug-resistant TB, CDC works with partners at the 
World Health Organization, partner U.S. government agencies, and ministries of health to:
ELIMINATING MDR TB WORLDWIDE
We are at a critical tipping point in the fight against MDR TB. The resistant forms are spreading and growing more 
resistant. If left unchecked, this may lead to a future where TB is no longer curable and TB deaths rise substantially . 
To contain this emerging crisis, we must act now to:
CURE
Identify better treatment regimens that 
cure patients faster with fewer side eects
Improve clinical management practices 
Work with MOHs to strengthen health 
systems critical to find and cure TB
PREVENT
Ensure appropriate treatment of all TB 
cases to prevent resistance
Break the cycle of transmission 
through infection control 
Scale up TB preventive and 
antiretroviral therapy for PLHIV to 
prevent TB disease
FIND
Strengthen laboratory networks  
and surveillance systems to enable rapid, 
accurate diagnosis of all TB and MDR TB cases
 Identify the best methods to diagnose TB among 
People Living with HIV (PLHIV) and children
Develop innovative approaches to find 
undiagnosed TB and MDR TB cases
Find and cure all existing cases of MDR TB 
Develop better tools to find and cure all forms of TB
Strengthen basic TB control programs to prevent  
drug-resistant strains from developing
http://www.cdc.gov/globalhivtbFind TB. Cure TB. Prevent TB.
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